LON:CLI - CLS Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 247 +2.50 (+1.02 %)
(As of 04/25/2019 04:00 PM ET)
Previous CloseGBX 244.50
Today's RangeGBX 238.50 - GBX 249
52-Week RangeGBX 195 - GBX 257
Volume3.07 million shs
Average Volume117,533 shs
Market Capitalization£1.01 billion
P/E Ratio8.10
Dividend Yield2.81%
BetaN/A
CLS Holdings plc, together with its subsidiaries, engages in the investment, development, and management of commercial properties in the United Kingdom, France, Germany, and France. It operates in two segments, Investment Property and Other Investments. The company also invests a hotel; and corporate bonds, shares, and other corporate investments. The company was founded in 1987 and is headquartered in London, the United Kingdom. CLS Holdings plc is a subsidiary of Mortstedt Family and Charity Trust.

Receive CLI News and Ratings via Email

Sign-up to receive the latest news and ratings for CLI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Real Estate Services
Sub-IndustryN/A
SectorReal Estate
CUSIPN/A
CIKN/A
Phone+44-20-75827766

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£133 million
Cash FlowGBX 24.90 per share
Book ValueGBX 275.50 per share

Profitability

Miscellaneous

Employees99
Market Cap£1.01 billion
Next Earnings DateN/A
OptionableOptionable

CLS (LON:CLI) Frequently Asked Questions

What is CLS's stock symbol?

CLS trades on the London Stock Exchange (LON) under the ticker symbol "CLI."

How often does CLS pay dividends? What is the dividend yield for CLS?

CLS announced a dividend on Thursday, March 7th. Investors of record on Thursday, April 4th will be given a dividend of GBX 4.70 per share on Monday, April 29th. This represents a yield of 1.91%. The ex-dividend date is Thursday, April 4th. This is a boost from CLS's previous dividend of $2.20. The official announcement can be accessed at this link. View CLS's Dividend History.

How were CLS's earnings last quarter?

CLS Holdings plc (LON:CLI) announced its quarterly earnings results on Wednesday, March, 7th. The company reported $12.80 EPS for the quarter, beating the Zacks' consensus estimate of $11.10 by $1.70. The business earned $133.40 million during the quarter. View CLS's Earnings History.

What price target have analysts set for CLI?

3 brokers have issued twelve-month price objectives for CLS's stock. Their predictions range from GBX 275 to GBX 300. On average, they anticipate CLS's stock price to reach GBX 283.33 in the next twelve months. This suggests a possible upside of 14.7% from the stock's current price. View Analyst Price Targets for CLS.

What is the consensus analysts' recommendation for CLS?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CLS in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CLS.

Has CLS been receiving favorable news coverage?

News coverage about CLI stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CLS earned a coverage optimism score of 1.5 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.

Who are some of CLS's key competitors?

What other stocks do shareholders of CLS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CLS investors own include Oracle (ORCL), Derwent London (DLN), IP Group (IPO), London Stock Exchange Group (LSE), Petrofac (PFC), Homeserve (HSV), Agios Pharmaceuticals (AGIO), Celgene (CELG), GIVAUDAN SA/ADR (GVDNY) and OptiBiotix Health (OPTI).

Who are CLS's key executives?

CLS's management team includes the folowing people:
  • Mr. Erik Henry Klotz, Exec. Chairman (Age 75)
  • Mr. Fredrik Widlund, CEO & Director (Age 51)
  • Mr. John H. Whiteley BA (ECON), FCA, CFO & Director (Age 60)
  • Mr. Sten Ake Mortstedt, Exec. Director (Age 79)
  • Mr. Greg Snow, Head of IT

How do I buy shares of CLS?

Shares of CLI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is CLS's stock price today?

One share of CLI stock can currently be purchased for approximately GBX 247.

How big of a company is CLS?

CLS has a market capitalization of £1.01 billion and generates £133 million in revenue each year. CLS employs 99 workers across the globe.

What is CLS's official website?

The official website for CLS is http://www.clsholdings.com.

How can I contact CLS?

CLS's mailing address is 86 Bondway, LONDON, SW8 1SF, United Kingdom. The company can be reached via phone at +44-20-75827766.


MarketBeat Community Rating for CLS (LON CLI)

Community Ranking:  3.6 out of 5 (star star star)
Outperform Votes:  309 (Vote Outperform)
Underperform Votes:  122 (Vote Underperform)
Total Votes:  431
MarketBeat's community ratings are surveys of what our community members think about CLS and other stocks. Vote "Outperform" if you believe CLI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel